Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease.

Articles >
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer’s disease.

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer’s disease.

Sonia Monge-García, María-Salud García-Ayllón, José Sánchez-Payá, Ruth Gasparini-Berenguer, María-Ángeles Cortés-Gómez, Javier Sáez-Valero, José-Antonio Monge-Argilés

Magazine Front. Neurol.

Year 2023

Vol: Pages(start-end) Sec. Neurological Biomarkers, Volume 14 - 2023

DOI https://doi.org/10.3389/fneur.2023.1124145

Research Groups

Altered molecular mechanism in Alzheimer’s disease and dementia

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer’s disease.

Research Groups

Login